North America Peripheral Vascular Devices Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Peripheral Vascular Disease is a blood circulation disorder that causes the blood vessels outside the heart and brain to block. In this disease, the flow of the blood decreases and the blood vessels become narrowed. Peripheral Vascular devices are used for the treatment of the blood vessels outside the brain and heart. The increasing number of patients suffering from peripheral artery occlusive disease is the primary factor that boosts up the market.

North America Peripheral Vascular Devices Market Segments Size & Growth:

North America Peripheral Vascular Devices Market is projected to reach approximately $4284.71 million by the end of 2024 with a CAGR of close to 7.20% during the forecast timeline 2018-2024. The significant factors that propel the growth of the North America Peripheral Vascular Devices Market are rising demand for minimally invasive procedures, changes in the lifestyle, growing the ageing population, advancement in the technology and increased peripheral vascular diseases.

North America Peripheral Vascular Devices Market Segments Share:

North America Peripheral Vascular Devices Market is segmented by an application which is further segmented into Stents, Angioplasty balloons, Inferior Vena Cava Filters, Embolic protection devices, Aortic stent-grafts, Peripheral vascular accessory devices, PTA balloon catheters, Synthetic surgical grafts, Chronic total occlusion devices and vascular closure devices. Among these devices, Embolic protection devices segment holds the most significant share in the market due to the increasing demand for the minimally invasive endovascular surgical method for removing atherosclerosis from the large blood vessels. By Geography, North America market is analysed under various regions namely the U.S., Canada, and Mexico.

North America Peripheral Vascular Devices Market Trends:

• Spyglass Direct Visualisation System by Boston Scientific is a single operator system for diagnosing and had launched Emerge PTCA dilatation catheter that offers exceptional deliverability.
• EnSite Precision is the new product launched by Abbott Laboratories which is used to visualise and navigate catheters in the heart during ablation procedures.
• The Imprint SX ablation platform with Thermosphere technology is introduced by Covidien that reduces the complexity and improves the accuracy of the soft tissue ablation.

North America Peripheral Vascular Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary critical players in the North America Peripheral Vascular Devices Market are:

• Boston Scientific Corporation
• Medtronic, Inc.
• Abbott Laboratories
• Cordis Corporation
• Covidien, Inc.